Filing Details
Lucid Diagnostics Inc. (NASDAQ:LUCD) filed a Form 8-K with the Securities and Exchange Commission on August 13, 2026, disclosing a material event.
8k filedNASDAQ:LUCD
Lucid Diagnostics Inc. (LUCD) Reports Material Event to SEC
Lucid Diagnostics Inc. (NASDAQ:LUCD) filed a Form 8-K with the Securities and Exchange Commission on August 13, 2026, disclosing a material event.
At publication ·
What changed
Lucid Diagnostics Inc. (NASDAQ:LUCD) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Lucid Diagnostics Inc. (NASDAQ:LUCD) filed a Form 8-K with the SEC on August 13, 2026, disclosing a material event that shareholders should be aware of.
- The company's stock trades at $0.96 with a market capitalization of $117.0 million.
- The specific nature of the material event is not disclosed in this article, though 8-K filings typically cover leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance.
Market Context
Lucid Diagnostics Inc.'s stock currently trades at $0.96 with a market capitalization of $117.0M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Lucid Diagnostics Inc.'s stock.
All SEC filings for Lucid Diagnostics Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View LUCD Stock Page
Frequently Asked Questions
Where can I read LUCD's SEC filings?
Browse all filings on our LUCD SEC filings page.
What types of SEC filings does Lucid Diagnostics Inc. file?
Public companies like Lucid Diagnostics Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.